FierceBiotech's 2019 Fierce 15

News & Press Releases

Quell Therapeutics named a “Fierce 15“ Company by FierceBiotech – QuellTX

Celsius Therapeutics on X: Q: What does every biotech company do when good things happen? A: Acquire swag, of course! @FierceBiotech / X

LabCentral on X: Did you miss today's webinar led by @fiercebiotech's @amirahalidrus about @ISS_Research with @NASA_Astronauts' @AstroSerena, @kernalbio's @Yusuf_erkul, and two amazing @space_station representatives? You're in luck - we've just posted the

PreciseDx featured in Fierce Biotech's Fierce 15 - PreciseDx

RenovoRx Named 2020 Winner in the Fierce Innovation Awards for Life Sciences - RenovoRx

News Sonder Capital

Canaan on X: We couldn't be happier to see Nocion named to @FierceBiotech 's #Fierce15 / X

VC funding trends in biotechnology

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors

FierceBiotech's 2019 Fierce 15

12.14.23 Pfizer wraps up $43B Seagen buyout, bolstering oncology presence; Bluebird eases Lyfgenia concerns with major coverage deal - Questex

Fierce Biotech Summit

Max Bayer - Staff Writer - FierceMarkets

Celsius Therapeutics on X: Q: What does every biotech company do when good things happen? A: Acquire swag, of course! @FierceBiotech / X